Abstract
Purpose
To develop a mapping algorithm for generating EQ-5D-3L utility scores from the PedsQL Generic Core Scales (PedsQL GCS) in patients with transfusion-dependent thalassemia (TDT).
Methods
The algorithm was developed using data from 345 TDT patients. Spearman’s rank correlation was used to evaluate the conceptual overlap between the instruments. Model specifications were chosen using a stepwise regression. Both direct and response mapping methods were attempted. Six mapping estimation methods ordinary least squares (OLS), a log-transformed response using OLS, generalized linear model (GLM), two-part model (TPM), Tobit and multinomial logistic regression (MLOGIT) were tested to determine the root mean squared error (RMSE) and mean absolute error (MAE). Other criterion used were accuracy of the predicted utility score, proportions of absolute differences that was less than 0.03 and intraclass correlation coefficient. An in-sample, leave-one-out cross validation was conducted to test the generalizability of each model.
Results
The best performing model was specified with three out of the four PedsQL GCS scales—the physical, emotional and social functioning score. The best performing estimation method for direct mapping was a GLM with a RMSE of 0.1273 and MAE of 0.1016, while the best estimation method for response mapping was the MLOGIT with a RMSE of 0.1597 and MAE of 0.0826.
Conclusion
The mapping algorithm developed using the GLM would facilitate the calculation of utility scores to inform economic evaluations for TDT patients when EQ-5D data is not available. However, caution should be exercised when using this algorithm in patients who have poor quality of life.
Similar content being viewed by others
Availability of data and material
The datasets used during the current study are available from the corresponding author on reasonable request.
References
Developing NICE Guidelines.: The Manual: National Institute for Health and Care Excellence (NICE), (2015)
Weinstein, M.C.: A QALY is a QALY is a QALY—or is it? In: North-Holland, (1988)
Whitehead, S.J., Ali, S.: Health outcomes in economic evaluation: the QALY and utilities. Br. Med. Bull. 96(1), 5–21 (2010)
Rascati, K.: Essentials of Pharmacoeconomics. Lippincott Williams & Wilkins, Philadelphia (2013)
Capellini, M., Taher, A.: Guidelines for the management for transfusion of thalassemia dependent (TDT). In: Thalassemia International Federation (TIF), (2014)
Vichinsky, E.P.: Changing patterns of thalassemia worldwide. Ann. N. Y. Acad. Sci. 1054, 18–24 (2005). https://doi.org/10.1196/annals.1345.003
Cappellini, M.D., Porter, J.B., Viprakasit, V., Taher, A.T.: A paradigm shift on beta-thalassaemia treatment: how will we manage this old disease with new therapies? Blood Rev. 32(4), 300–311 (2018). https://doi.org/10.1016/j.blre.2018.02.001
Wailoo, A.J., Hernandez-Alava, M., Manca, A., Mejia, A., Ray, J., Crawford, B., Botteman, M., Busschbach, J.: Mapping to estimate health-state utility from non-preference-based outcome measures: an ISPOR good practices for outcomes research task force report. Value Health 20(1), 18–27 (2017)
Hernández Alava, M., Wailoo, A., Wolfe, F., Michaud, K.: A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes. Med. Decis. Mak. 34(7), 919–930 (2014)
Dakin, H., Abel, L., Burns, R., Yang, Y.: Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement. Health Qual. Life Outcomes 16(1), 31 (2018)
Pullenayegum, E.M., Tarride, J.E., Xie, F., Goeree, R., Gerstein, H.C., O’Reilly, D.: Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate? Value Health 13(4), 487–494 (2010)
Mitsakakis, N., Bremner, K.E., Tomlinson, G., Krahn, M.: Exploring the benefits of transformations in health utility mapping. Med. Decis. Mak. 40(2), 183–197 (2020). https://doi.org/10.1177/0272989X19896567
Brazier, J.E., Yang, Y., Tsuchiya, A., Rowen, D.L.: A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur. J. Health Econ. 11(2), 215–225 (2010). https://doi.org/10.1007/s10198-009-0168-z
Mukuria, C., Rowen, D., Harnan, S., Rawdin, A., Wong, R., Ara, R., Brazier, J.: An updated systematic review of studies mapping (or cross-walking) measures of health-related quality of life to generic preference-based measures to generate utility values. Appl. Health Econ. Health Policy 17(3), 295–313 (2019). https://doi.org/10.1007/s40258-019-00467-6
Khan, K.A., Petrou, S., Rivero-Arias, O., Walters, S.J., Boyle, S.E.: Mapping EQ-5D utility scores from the PedsQL™ generic core scales. Pharmacoeconomics 32(7), 693–706 (2014)
Payakachat, N., Tilford, J.M., Kuhlthau, K.A., van Exel, N.J., Kovacs, E., Bellando, J., Pyne, J.M., Brouwer, W.B.: Predicting health utilities for children with autism spectrum disorders. Autism Res. 7(6), 649–663 (2014)
Mpundu-Kaambwa, C., Chen, G., Russo, R., Stevens, K., Petersen, K.D., Ratcliffe, J.: Mapping CHU9D utility scores from the PedsQL TM 4.0 SF-15. Pharmacoeconomics 35(4), 453–467 (2017)
Lambe, T., Frew, E., Ives, N.J., Woolley, R.L., Cummins, C., Brettell, E.A., Barsoum, E.N., Webb, N.J., Team, P.T.: Mapping the Paediatric Quality of Life Inventory (PedsQL™) Generic Core Scales onto the Child Health Utility Index-9 Dimension (CHU-9D) score for economic evaluation in children. Pharmacoeconomics 36(4), 451–465 (2018)
Sweeney, R., Chen, G., Gold, L., Mensah, F., Wake, M.: Mapping PedsQLTM scores onto CHU9D utility scores: estimation, validation and a comparison of alternative instrument versions. Qual. Life Res. 29(3), 639–652 (2020). https://doi.org/10.1007/s11136-019-02357-9
Varni, J. W., Seid, M., Rode, C.A.: The PedsQL: measurement model for the pediatric quality of life inventory. Med. Care 37(2), 126–139 (1999). https://doi.org/10.1097/00005650-199902000-00003
Shafie, A.A., Vasan Thakumar, A.: Multiplicative modelling of EQ-5D-3L TTO and VAS values. Eur. J. Health. Econ. 21(9), 1411–1420 (2020). https://doi.org/10.1007/s10198-020-01233-5
Deb, P., Norton, E.C., Manning, W.G.: Health Econometrics Using Stata. Stata Press, College Station (2017)
Huang, I.C., Frangakis, C., Atkinson, M.J., Willke, R.J., Leite, W.L., Vogel, W.B., Wu, A.W.: Addressing ceiling effects in health status measures: a comparison of techniques applied to measures for people with HIV disease. Health Serv. Res. 43(1 Pt 1), 327–339 (2008). https://doi.org/10.1111/j.1475-6773.2007.00745.x
Belotti, F., Deb, P., Manning, W.G., Norton, E.C.: twopm: Two-part models. Stand. Genom. Sci. 15(1), 3–20 (2015)
Wilhelm, M.O.: Practitioners’ corner: practical considerations for choosing between Tobit and SCLS or CLAD estimators for censored regression models with an application to charitable giving. Oxf. Bull. Econ. Stat. 70(4), 559–582 (2008)
Kotz, S., Read, C.B., Balakrishnan, N., Vidakovic, B.: Encyclopedia of Statistical Sciences, 16 Vol. Wiley, New York (2005)
Koo, T. K., Li, M.Y.: A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J. Chiropr. Med. 15(2), 155–163 (2016). https://doi.org/10.1016/j.jcm.2016.02.012
Liljequist, D., Elfving, B., Skavberg Roaldsen, K.: Intraclass correlation - A discussion and demonstration of basic features. PloS One 14(7), e0219854 (2019). https://doi.org/10.1371/journal.pone.0219854
StataCorp: Stata Statistical Software: Release 14. College Station, StataCorp LP (2015)
Petrou, S., Rivero-Arias, O., Dakin, H., Longworth, L., Oppe, M., Froud, R., Gray, A.: Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement. PharmacoEconomics 33(10), 985–991 (2015). https://doi.org/10.1007/s40273-015-0319-2
Hyndman, R.J., Athanasopoulos, G.: Forecasting: principles and practice. OTexts (2018)
Oppe, M., Devlin, N.J., Szende, A.: EQ-5D Value Sets: Inventory, Comparative Review and User Guide. Springer, Berlin (2007)
Le, Q.A., Doctor, J.N.: Probabilistic mapping of descriptive health status responses onto health state utilities using Bayesian networks: an empirical analysis converting SF-12 into EQ-5D utility index in a national US sample. Med. Care 49(5), 451–460 (2011). https://doi.org/10.1097/MLR.0b013e318207e9a8
Rand, S., Caiels, J.: Using proxies to assess quality of life: a review of the issues and challenges. Discussion Paper 2899 (2015). http://www.pssru.ac.uk/archive/pdf/4980.pdf
Acknowledgements
The authors would like to thank the Director General of the Ministry of Health Malaysia for the permission to publish the research findings of this study. We also would like to acknowledge the paediatricians, interviewers (Faizah Mohd Hanapiah, Mohd Hafizudin Mohd Salim, Mohamad Khudri Khairudin, Siti Nur Syahida Abdul Jalil, Muhammad Farid Abdul Ghaffar, Nur Liyana Kamaronzaman, Mohd Saharudin Mat Salim, Nurul Syafika Mohd Hairi, Analisa Coldelia Anak Rumpu, Elvyshirah Hadirin, Raphaela Romanus, Nur Asyilla Aslinda Mohd Nasir, Nurzuliana Hassim, Mohd Afiq Mohs Azis, Hamizah Kharber, Nur Athirah Abdul Razak, Nor Afifa Mazlan, Mohd Afiq Mohd Sulaiman, Nurain Syahirah Abu Bakar), patients, parents and caregivers from the various hospitals in Malaysia for participating and their cooperation in making this study possible. The authors would also like to thank Dr Annushiah Vasan Thakumar for her assistance and input during the analysis phase of the manuscript.
Funding
No financial support was received for this study.
Author information
Authors and Affiliations
Contributions
AAS: was involved in the revision of the paper for intellectual content and in the design, interpretation, analysis of data and proofreading the manuscript; IKC: was involved in the drafting of the manuscript, analysis and interpretation of the data; JWHY: was involved in the design, collection, training, validation of the study and data and proofreading the manuscript; NSM: was involved in the training, validation of the study and data and proofreading the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Ethics approval
This study was registered with the Malaysian National Medical Research Registry (NMRR-17-2614-38966). This study was also approved by the Malaysian Research and Ethics Committee.
Consent to participate
Prior to each interview, written consents and assents were obtained from both caregivers and patients who were willing to participate.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Shafie, A.A., Chhabra, I.K., Wong, J. et al. Mapping PedsQL™ Generic Core Scales to EQ-5D-3L utility scores in transfusion-dependent thalassemia patients. Eur J Health Econ 22, 735–747 (2021). https://doi.org/10.1007/s10198-021-01287-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10198-021-01287-z